---
schema_version: "secwatch.filing_event.v1"
accession: "0000010795-24-000064"
form_type: "8-K"
ticker: "BDX"
cik: "0000010795"
company_name: "BECTON DICKINSON & CO"
filed_at: "2024-08-01T23:59:59+00:00"
generated_at: "2026-05-31T13:38:15.085381+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.9
calibrated_materiality_score: 0.9
confidence: "high"
source: SEC EDGAR
---

# BD Q3 adjusted EPS $3.50 beats, raises FY24 guidance; acquires Edwards Critical Care for $4.2B

## Summary
- Revenue $4.99B as reported, $5.057B adjusted; organic revenue growth 5.2% YoY.
- GAAP diluted EPS $1.68 (+23.5% YoY); adjusted diluted EPS $3.50 (+18.2% YoY).
- Year-to-date free cash flow $2.2B, up over 100% YoY.
- FY2024 adjusted EPS guidance raised to $13.05-$13.15; organic revenue growth guidance 5.0%-5.25%.
- Announced agreement to acquire Edwards Lifesciences' Critical Care Product Group for $4.2B.

## SEC filing metadata
- accession: 0000010795-24-000064
- form_type: 8-K
- ticker: BDX
- cik: 0000010795
- company_name: BECTON DICKINSON & CO
- filed_at: 2024-08-01T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.9
- calibrated_materiality_score: 0.9
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/10795/000001079524000064/0000010795-24-000064-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/10795/000001079524000064/bdx-20240801.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000010795-24-000064
- JSON: https://secwatch.observer/filing/0000010795-24-000064.json
- Plain text: https://secwatch.observer/filing/0000010795-24-000064.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.